Your Article Summary
Inhibition of Chemokine Receptor Expression on Uveal Melanomas by CXCR4 siRNA Blocks Tumor Cell Invasion and Liver Metastasis of Uveal Melanoma Cells
Investigative Ophthalmology and Visual Science, 06/25/09
Li H et al. - CXCR4 is a key chemokine receptor that may account for the organ-specific homing of human uveal melanomas to the liver, which contains significant quantities of CXCL2, the only known ligand for CXCR4. CXCR4 is a potential therapeutic target for preventing the initial establishment of liver metastases, but has limited application for use in advanced liver tumors.
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Genetics of uveal melanoma
Expert Review of Ophthalmology, 12/07/09
Ocular adnexal diffuse large B-cell lymphoma: local disease correlates with better outcomes
Eye, 12/04/09
Possible Implications of MCAM Expression in Metastasis and Non-Metastatic of Primary Uveal Melanoma Patients
Current Eye Research, 12/03/09

See Latest Articles